Kurk Functional Foods

United Kingdom|Biotechnology

Overview

We have created the most effective alternative to Ibuprofen, from 100% plants.

Founded by two cancer survivors (and best friends) Dr Harrison Weisinger and Trent Scanlen, we are vertically integrated and are well positioned to scale rapidly into two huge markets worldwide - Herbal medicine ($550B) and Functional Foods ($309B).

After 4 years of R&D in our purpose built lab in Twickenham, we have cleanly distilled curcumin into a micellar emulsion and combined it with other functional plant extracts to create a delicious drink in 3 flavours.

We have achieved over £3.5m in online sales and have pioneered incredible scientific and medical results. We now want to scale our KURK brand, enter retail and unlock distribution partnerships.

Company Highlights

Ut dignissim eget felis non ultrices. Vivamus fermentum erat at velit varius molestie.

Duis vitae mi neque.

Donec tincidunt, dolor luctus lobortis ultrices, turpis eros cursus turpis, maximus tempor lectus lectus vel diam.

Proin neque lacus, semper vel ex at, eleifend rhoncus est.

Cras non nisi urna. Sed feugiat dignissim erat, eget convallis nisl blandit a. Nullam fringilla diam eget dui placerat f

Open an account to get
access to more details

Problem and Solution

Pellentesque tempor a risus in elementum. Proin malesuada mauris et mauris bibendum laoreet.

Vivamus maximus nulla volutpat, ornare lorem a, vulputate enim.

Open an account to get
access to more details

Competitive Advantage

Open an account to get
access to more details

Current Shareholders & Investors

Ut dignissim eget felis non ultrices. Vivamus fermentum erat at velit varius molestie.

Duis vitae

Open an account to get
access to more details

See more exiting opportunities on CapitalHQ

Wholesale Investor

Wholesale Investor, with over 45,000 subscribers, is a leading private capital marketplace operating across Australia, Singapore, and the UK. It has a 15-year track record of connecting private market opportunities with HNW, professional, and family office investors. In just 4 years, our product...

Australia AUD

Fintech Series B+ Software-as-a-Service

PRIMAL ORGANIX

Primal Organix has created the world’s first botanically derived Terpene blended anti-anxiety health supplement that manages anxiety in minutes. Our purpose is to support positive mental ill-health and well-being in all human beings.

Australia AUD

Healthcare Series A

Sustainable Fintech Fund

Startupbootcamp, the #1 Accelerator in the world outside of the US, established in 2010, operates in 27 countries around the globe, has accelerated over 1600+ startups with a success rate of 76% remaining active, raised over $2.2B in total funding, a network of more than 300+ investors, 5000...

Australia AUD

Fintech Fund

Pictor

Powering diagnostics with protein signatures. Pictor is transforming health with its patented platform providing accessible, affordable, and scalable diagnostic solutions across the human and animal health verticals. PictArray can detect up to 10 diseases or biomarkers from one small serum, milk,...

New Zealand NZD

Biotechnology Series B+

Kurk Functional Foods

Overview

Company Highlights

Problem and Solution

Competitive Advantage

Current Shareholders & Investors